EUGENE MANGIERI: Open Payments
NPI 1063513885 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 35 payments from 7 companies in 2025. Trend: 2023 $1,081 · 2024 $1,044 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $273 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $98 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Forte Bio-Pharma LLC | 2 | $37 |
| Lundbeck LLC | 2 | $35 |
| Indivior Inc. | 1 | $35 |
Products named: REXULTI, RELISTOR, Sunosi, Belbuca, PROLATE, SUBLOCADE.
Industry payments across AL — which companies pay providers there.
